Seroxat
May 13 2006, Pratyush

GlaxoSmithKline, the manufacturer of Seroxat, an anti depressant drug, said that the drug may cause adults and children to become suicidal.

GSK earlier had denied any problem in the drug, now advices the doctors, all over Britain, about its potential...

Related Stories
Most Recent Most Popular Most Commented
(0)
AP, Research Triangle Park
GlaxoSmithKline, the world’s second-largest drugmaker, says it is boosting production of antiviral medication as reports of swine flu grow.
made popular May 1 2009
(0)
AP, London
GlaxoSmithKline, the world’s second largest drug maker by revenues, posted a 13 percent drop in net profit for the first quarter on Wednesday, as strong sales in...
made popular Apr 22 2009
(0)
AP, London
British drug maker GlaxoSmithKline PLC said Monday it will pay $2.9 billion to buy American dermatology business Stiefel Laboratories Inc.
made popular Apr 20 2009
(0)
AP,
British drugmaker GlaxoSmithKline PLC is reportedly nearing a deal to purchase privately held U.S. skincare products maker Stiefel Laboratories Inc. for about $3...
made popular Apr 19 2009
(0)
AP, London
Drug makers GlaxoSmithKline PLC and Pfizer Inc. said Thursday they plan to create a new company to invest in the research and development of HIV treatments.
made popular Apr 16 2009
(0)
AP, Washington
A marketing campaign for a GlaxoSmithKline prostate drug has drawn complaints from federal regulators, who said the space-themed advertisement is misleading.
made popular Feb 27 2009
(0)
AP, New York
Drug maker GlaxoSmithKline PLC says it will cut drug prices to the 50 poorest countries in the world and use 20 percent of its profits from those countries to build...
made popular Feb 14 2009
(0)
AP, New York
U.K. drug developer GlaxoSmithKline PLC is reportedly in talks to buy Indian generic drug developer Piramal Healthcare Ltd. for about $1.5 billion.
made popular Feb 6 2009
(0)
AP, London
Drug maker GlaxoSmithKline PLC said Friday it has resubmitted a new drug application to U.S. authorities for Solzira, the restless legs syndrome drug it has developed...
made popular Jan 9 2009
(0)
AP, London
GlaxoSmithKline PLC and Archemix Corp. said Tuesday they will work together to develop drugs for inflammatory diseases in a deal that could be worth as much as $1.4...
made popular Dec 23 2008
(0)
AP, London
GlaxoSmithKline PLC and Archemix Corp. said Tuesday they will work together to develop drugs for inflammatory diseases in a deal that could be worth as much as $1.4...
made popular Dec 23 2008
(0)
AP, London
The London-based drug maker GlaxoSmithKline is banning corporate political contributions around the world.
made popular Dec 22 2008
(0)
AP, London
GlaxoSmithKline said Monday it has agreed to buy Bristol-Myers Squibb Pakistan Ltd. and certain associated trademarks for around $36.5 million, bolstering its emerging...
made popular Dec 22 2008
(0)
AP, Trenton
Drugmaker GlaxoSmithKline PLC is making a big investment in a new type of drug for the gigantic heart disease market, announcing Thursday it is starting a...
made popular Dec 18 2008
(0)
AP, London
British drug maker GlaxoSmithKline PLC said Wednesday it will pay U.S. biotechnology company Dynavax Technologies Corp. $10 million upfront in a research deal to...
made popular Dec 17 2008
(0)
AP, London
British drug maker GlaxoSmithKline PLC said Thursday that the Dutch government has selected its cervical cancer vaccine Cervarix for a nationwide vaccination program.
made popular Nov 20 2008
(0)
AP, London
British drug maker GlaxoSmithKline PLC said Tuesday it plans to close one of its English plants, which employs 620, by 2013 because the majority of drugs made there are...
made popular Nov 11 2008
(0)
AP, Trenton
British drugmaker GlaxoSmithKline PLC is restructuring its U.S. operations, starting with reducing its U.S. sales force by 1,000.
made popular Nov 5 2008
(0)
AP, London
GlaxoSmithKline PLC won a recommendation from European regulators Thursday that it be allowed to sell its weight loss drug Alli over the counter in Europe.
made popular Oct 23 2008
(0)
AP, London
GlaxoSmithKline PLC has posted better-than-expected third-quarter results as the weak British pound helped outweigh the impact of increased generic competition in the...
made popular Oct 22 2008
All Stories
Most Recent Most Popular Most Commented
(0)
After space, it’s medical science only where we’ve a lot to dig out and we are moving fast on both fronts too. The year 2006 saw major achievements in...
made popular Jan 11 2007